Qube Research & Technologies (QRT)
TENX icon

Qube Research & Technologies (QRT)’s Tenax Therapeutics TENX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452K Buy
+28,285
New +$383K ﹤0.01% 2770
2024
Q3 		– Sell
-4,407
Closed -$13.4K – 4099
2024
Q2 		$13.4K Hold
4,407
– – ﹤0.01% 2935
2024
Q1 		$18.7K Buy
4,407
+4,401
+73,350% +$33.8K ﹤0.01% 3708
2023
Q4 		$137 Buy
+6
New +$144 ﹤0.01% 4003

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return